Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Alterations in DNA Methylation Status Associated with Gulf War Illness.

Trivedi MS, Abreu MM, Sarria L, Rose N, Ahmed N, Beljanski V, Fletcher MA, Klimas NG, Nathanson L.

DNA Cell Biol. 2019 Jun;38(6):561-571. doi: 10.1089/dna.2018.4469. Epub 2019 Mar 28.

PMID:
30920300
2.

Pleiotropic roles of autophagy in stem cell-based therapies.

Beljanski V, Grinnemo KH, Österholm C.

Cytotherapy. 2019 Apr;21(4):380-392. doi: 10.1016/j.jcyt.2019.02.007. Epub 2019 Mar 12. Review.

PMID:
30876741
3.

Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells.

Chrobok M, Dahlberg CIM, Sayitoglu EC, Beljanski V, Nahi H, Gilljam M, Stellan B, Sutlu T, Duru AD, Alici E.

Cancers (Basel). 2019 Jan 10;11(1). pii: E69. doi: 10.3390/cancers11010069.

4.

Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.

Trivedi MS, Oltra E, Sarria L, Rose N, Beljanski V, Fletcher MA, Klimas NG, Nathanson L.

PLoS One. 2018 Jul 23;13(7):e0201066. doi: 10.1371/journal.pone.0201066. eCollection 2018.

5.

Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity.

Olagnier D, Lababidi RR, Hadj SB, Sze A, Liu Y, Naidu SD, Ferrari M, Jiang Y, Chiang C, Beljanski V, Goulet ML, Knatko EV, Dinkova-Kostova AT, Hiscott J, Lin R.

Mol Ther. 2017 Aug 2;25(8):1900-1916. doi: 10.1016/j.ymthe.2017.04.022. Epub 2017 May 17.

6.

Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.

Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J.

J Virol. 2015 Oct;89(20):10612-24. doi: 10.1128/JVI.01526-15. Epub 2015 Aug 12.

7.

The intersection between viral oncolysis, drug resistance, and autophagy.

Beljanski V, Chiang C, Hiscott J.

Biol Chem. 2015 Dec;396(12):1269-80. doi: 10.1515/hsz-2015-0147. Review.

PMID:
26068902
8.

Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.

Chiang C, Beljanski V, Yin K, Olagnier D, Ben Yebdri F, Steel C, Goulet ML, DeFilippis VR, Streblow DN, Haddad EK, Trautmann L, Ross T, Lin R, Hiscott J.

J Virol. 2015 Aug;89(15):8011-25. doi: 10.1128/JVI.00845-15. Epub 2015 May 27.

9.

Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells.

Olagnier D, Peri S, Steel C, van Montfoort N, Chiang C, Beljanski V, Slifker M, He Z, Nichols CN, Lin R, Balachandran S, Hiscott J.

PLoS Pathog. 2014 Dec 18;10(12):e1004566. doi: 10.1371/journal.ppat.1004566. eCollection 2014 Dec.

10.

Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy.

Shulak L, Beljanski V, Chiang C, Dutta SM, Van Grevenynghe J, Belgnaoui SM, Nguyên TL, Di Lenardo T, Semmes OJ, Lin R, Hiscott J.

J Virol. 2014 Mar;88(5):2927-40. doi: 10.1128/JVI.03406-13. Epub 2013 Dec 26.

11.

BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysis.

Samuel S, Beljanski V, Van Grevenynghe J, Richards S, Ben Yebdri F, He Z, Nichols C, Belgnaoui SM, Steel C, Goulet ML, Shamy A, Brown D, Abesada G, Haddad EK, Hiscott J.

Mol Ther. 2013 Jul;21(7):1413-23. doi: 10.1038/mt.2013.91. Epub 2013 May 21.

12.

The use of oncolytic viruses to overcome lung cancer drug resistance.

Beljanski V, Hiscott J.

Curr Opin Virol. 2012 Oct;2(5):629-35. doi: 10.1016/j.coviro.2012.07.006. Epub 2012 Aug 19. Review.

PMID:
22910124
13.

Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.

Beljanski V, Lewis CS, Smith CD.

Cancer Biol Ther. 2011 Mar 1;11(5):524-34. Epub 2011 Mar 1.

14.

Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.

Beljanski V, Knaak C, Zhuang Y, Smith CD.

Invest New Drugs. 2011 Dec;29(6):1132-42. doi: 10.1007/s10637-010-9452-0. Epub 2010 May 18.

15.

A novel sphingosine kinase inhibitor induces autophagy in tumor cells.

Beljanski V, Knaak C, Smith CD.

J Pharmacol Exp Ther. 2010 May;333(2):454-64. doi: 10.1124/jpet.109.163337. Epub 2010 Feb 23.

16.

Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.

French KJ, Zhuang Y, Maines LW, Gao P, Wang W, Beljanski V, Upson JJ, Green CL, Keller SN, Smith CD.

J Pharmacol Exp Ther. 2010 Apr;333(1):129-39. doi: 10.1124/jpet.109.163444. Epub 2010 Jan 8.

17.
18.

"Skittish" Abca2 knockout mice display tremor, hyperactivity, and abnormal myelin ultrastructure in the central nervous system.

Mack JT, Beljanski V, Soulika AM, Townsend DM, Brown CB, Davis W, Tew KD.

Mol Cell Biol. 2007 Jan;27(1):44-53. Epub 2006 Oct 23.

19.

The ATP-binding cassette transporter ABCA2 as a mediator of intracellular trafficking.

Mack JT, Beljanski V, Tew KD, Townsend DM.

Biomed Pharmacother. 2006 Nov;60(9):587-92. Epub 2006 Aug 31. Review.

21.

Evaluation of lipophilins as determinants of tumor cell response to estramustine.

Tucker JM, Lipatova Z, Beljanski V, Townsend DM, Tew KD.

J Pharmacol Exp Ther. 2005 Dec;315(3):1158-62. Epub 2005 Aug 24.

PMID:
16120813
22.

Characterization of the ATPase activity of human ATP-binding cassette transporter-2 (ABCA2).

Beljanski V, Soulika A, Tucker JM, Townsend DM, Davis W Jr, Tew KD.

In Vivo. 2005 Jul-Aug;19(4):657-60.

23.

DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs.

Beljanski V, Marzilli LG, Doetsch PW.

Mol Pharmacol. 2004 Jun;65(6):1496-506.

PMID:
15155842

Supplemental Content

Loading ...
Support Center